GHTM

Global Health and Tropical Medicine

  • GHTM
    • Vision
    • Mission
    • Governance
    • Scientific Advisory Board
  • News
    • Outreach
    • Events
      • GHTM Sessions
      • Workshops
    • Articles
    • Jobs
  • Research
    • Cross-cutting issues
      • Global Pathogen Dispersion and Population Mobility
      • Drug Discovery and Drug Resistance
      • Diagnostics
      • Public Health Information
      • Fair Research Partnerships
    • Research Groups
      • PPS – Population health, policies and services
      • THOP – TB, HIV and opportunistic diseases and pathogens
      • VBD – Vector borne diseases and pathogens
      • IHC – Individual health care
    • Research in numbers
      • 2020
      • 2019
      • 2018
      • 2017
    • Projects
      • Ongoing Projects
    • Members
      • Population health, policies and services
        • PPS PhD members
        • PPS non PhD members
      • TB, HIV and opportunistic diseases and pathogens
        • THOP PhD members
        • THOP non PhD members
      • Vector-borne diseases and pathogens
        • VBD PhD members
        • VBD non PhD members
      • Individual Health Care
        • IHC PhD members
        • IHC non PhD members
      • Technical / administrative support
  • Publications
  • Education
    • Master Theses
    • PhD Theses
  • Services
Home / Publicações / Hepatitis delta: In vitro evaluation of cytotoxicity and cytokines involved in PEG-IFN therapy

Hepatitis delta: In vitro evaluation of cytotoxicity and cytokines involved in PEG-IFN therapy

  • Autores: Larissa Deadame de Figueiredo Nicolete, Celso Vladimiro Cunha, João Paulo Tavanez, Mariana Tomazini Pinto, Evandra Strazza Rodrigues, Simone Kashima, Dimas Tadeu Covas, Juan Miguel Villalobos-Salcedo, Roberto Nicolete
  • Ano de Publicação: 2021
  • Journal: International Immunopharmacology, vol 91, art 107302
  • Link: https://doi.org/10.1016/j.intimp.2020.107302

HIGHLIGHTS

• HBsAg and SHDAg display toxicity in co-cultured cells (Jurkat + THP-1).
• PEG-IFN reduces cytotoxicity profile and increases IL-12, IL-2 and IFN-γ production.
• PEG-IFN restores the production of IFN-γ by SHDAg-stimulated cells.

ABSTRACT

The treatment for hepatitis Delta virus (HDV) still consists of Pegylated interferon (PEG-IFN) combined with inhibitors of Hepatitis B virus (HBV) replication. In some patients may be occur a virological response, which means a negative HDV RNA 6 months after stopping treatment. In this study it was conducted an in vitro approach with the aim to mimic possible immunological events that are observed in patients responding to PEG-IFN therapy. Jurkat cells (human T lymphocyte cell line) were employed alone or co-cultured with THP-1 (human monocytic cell line) and stimulated with controls and HBV Surface Antigen (HBsAg), Small-Delta Antigen (SHDAg), and HBsAg + SHDAg combined. Twenty-four hours stimulation with SHDAg and/or HBSAg led to a toxic profile in a co-culture condition and cell supernatants were collected for cytokines quantification. PEG-IFN was added and cells were incubated for additional 24 h. Co-cultured cells incubated with the association (SHDAg + PEG-IFN) significantly produced levels of IFN-γ, IL-2 and IL-12. On the other hand, the HBsAg alone was able to inhibit the production of IFN-γ, suggesting that this antigen may hinder the treatment exclusively with PEG-IFN.

 

KEYWORDS

HBV; HDV; PEG-IFN; Cytokines.

Share this:

  • Click to share on Facebook (Opens in new window)
  • Click to share on Twitter (Opens in new window)
  • Click to share on LinkedIn (Opens in new window)
  • Click to share on Pinterest (Opens in new window)
  • Click to share on WhatsApp (Opens in new window)
  • Click to print (Opens in new window)

Events

“Python Applied to Biomedical Sciences course allowed students to understand the applications of this programming language”

  The first edition of the course "Python Applied to Biomedical Sciences" was organized and … [Read More...]

Status of COVID-19 Transmission in Secondary Schools in Europe – First results and evidence gathered within the framework of the European EUCARE project with the participation of GHTM

EUCARE Project – Status of COVID-19 Transmission in Secondary Schools in Europe – First results and … [Read More...]

Members of PPS-GHTM Research Group attended the 17th World Congress on Public Health

  Researchers, Master and PhD students from the PPS-GHTM Research Group attended the 17th … [Read More...]

Erasmus+: IHMT-NOVA welcomes two researchers from the University of Cape Verde

IHMT-NOVA welcomes two researchers from the University of Cape Verde. Between 5th and 9th of June, … [Read More...]

Call for PhD Studentships

The Institute of Hygiene and Tropical Medicine (IHMT), Universidade Nova de Lisboa (NOVA), through … [Read More...]

IHMT | GHTM – APPLICATIONS ARE OPEN!

IHMT | GHTM - Applications are open for three research vacancies:   One position - PhD … [Read More...]

About GHTM

GHTM is a R&D Center that brings together researchers from IHMT with a track record in Tropical Medicine and International/Global Health. It aims at strengthening Portugal's role as a leading partner in the development and implementation of a global health research agenda. Our evidence-based interventions contribute to the promotion of equity in health and to improve the health of populations.

Contacts

Rua da Junqueira, 100
1349-008 Lisboa
Portugal
+351 213 652 600
+351 213 632 105

  • Facebook
  • YouTube

Subscribe Newsletter

  • How to get to GHTM/IHMT
  • GHTM Sessions
  • Research Groups
  • Cross-cutting issues
© Copyright 2023 IHMT-UNL Todos os Direitos Reservados.
  • Universidade Nova de Lisboa
  • Fundação para a Ciência e a Tecnologia

    Project UID/Multi/04413/2013